Cargando…

Wearable cardioverter‐defibrillator: friend or foe in suspected myocarditis?

AIM: Wearable cardioverter defibrillator (WCD, LifeVest, and Zoll) therapy has become a useful tool to bridge a temporarily increased risk for sudden cardiac death. However, despite extensive use, there is a lack of evidence whether patients with myocarditis and impaired LVEF may benefit from treatm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blaschke, Florian, Lacour, Philipp, Dang, Phi Long, Parwani, Abdul Shokor, Hohendanner, Felix, Walter, Thula, Klingel, Karin, Kühl, Uwe, Heinzel, Frank R., Sherif, Mohammad, Boldt, Leif‐Hendrik, Pieske, Burkert, Tschöpe, Carsten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Short Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318471/ https://www.ncbi.nlm.nih.gov/pubmed/33932118 http://dx.doi.org/10.1002/ehf2.13340

Ejemplares similares

The effect of iron deficiency on cardiac resynchronization therapy: results from the RIDE‐CRT Study
por: Lacour, Philipp, et al.
Publicado: (2020)

First clinical experience of high-power ablation of atrial fibrillation with a novel contact force-sensing gold-tip catheter
por: Parwani, Abdul Shokor, et al.
Publicado: (2022)

Left atrial strain predicts recurrence of atrial arrhythmias after catheter ablation of persistent atrial fibrillation
por: Parwani, Abdul Shokor, et al.
Publicado: (2017)

Benefit of a wearable cardioverter defibrillator for detection and therapy of arrhythmias in patients with myocarditis
por: Tscholl, Verena, et al.
Publicado: (2021)

Oxidative Stress and Inflammatory Modulation of Ca(2+) Handling in Metabolic HFpEF-Related Left Atrial Cardiomyopathy
por: Bode, David, et al.
Publicado: (2020)

Impaired Relaxation and Reduced Lusitropic Reserve in Atrial Myocardium in the Obese Patients
por: Wen, Yan, et al.
Publicado: (2021)

Atrial remodelling in heart failure: recent developments and relevance for heart failure with preserved ejection fraction
por: Hohendanner, Felix, et al.
Publicado: (2018)

COVID19-associated cardiomyocyte dysfunction, arrhythmias and the effect of Canakinumab
por: Dimai, Sanzio, et al.
Publicado: (2021)

Implantable loop recorders in patients with unexplained syncope: Clinical predictors of pacemaker implantation
por: Huemer, Martin, et al.
Publicado: (2019)

Third‐degree AV block sensitive to prednisolone 72 hours post AVNRT ablation
por: Parwani, Abdul S., et al.
Publicado: (2017)

Contact force mapping during catheter ablation for atrial fibrillation: procedural data and one-year follow-up
por: Wutzler, Alexander, et al.
Publicado: (2014)

Early recurrence of myocarditis with atrioventricular block while wearing a wearable cardioverter-defibrillator after fulminant myocarditis: A case report
por: Ikebe, Ryokan, et al.
Publicado: (2023)

First experience with the wearable cardioverter defibrillator in the Netherlands
por: Knops, R. E., et al.
Publicado: (2011)

Wearable cardioverter defibrillator: Bridge or alternative to implantation?
por: Barraud, Jeremie, et al.
Publicado: (2017)

Multiparameter Monitoring with a Wearable Cardioverter Defibrillator
por: Rohrer, Ursula, et al.
Publicado: (2021)

Usage of the wearable cardioverter-defibrillator during pregnancy
por: Olic, J.-Jacqueline, et al.
Publicado: (2022)

Atrial rhythm influences catheter tissue contact during radiofrequency catheter ablation of atrial fibrillation: comparison of contact force between sinus rhythm and atrial fibrillation
por: Matsuda, Hisao, et al.
Publicado: (2015)

Variations in local calcium signaling in adjacent cardiac myocytes of the intact mouse heart detected with two-dimensional confocal microscopy
por: Hammer, Karin P., et al.
Publicado: (2015)

An appropriate shock of the wearable cardioverter-defibrillator in an outpatient setting
por: Kishihara, Jun, et al.
Publicado: (2016)

Bridge to avoid ICD implantation with wearable cardioverter defibrillators
por: Zoppo, Franco, et al.
Publicado: (2020)

A Tragic Case of Wearable Cardioverter-Defibrillator Failure
por: Vinas, Ariel, et al.
Publicado: (2021)

Phantom Shocks Associated With a Wearable Cardioverter Defibrillator
por: Delle Donna, Paul, et al.
Publicado: (2021)

Experience with a Wearable Cardioverter-defibrillator in 436 Patients
por: Nägele, Herbert, et al.
Publicado: (2022)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Telbivudine in chronic lymphocytic myocarditis and human parvovirus B19 transcriptional activity
por: Van Linthout, Sophie, et al.
Publicado: (2018)

Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator—The PROLONG Study
por: Duncker, David, et al.
Publicado: (2017)

The impact of wearable cardioverter-defibrillator use on long-term decision for implantation of a cardioverter-defibrillator in a semirural acute care hospital
por: Sinha, Anil-Martin, et al.
Publicado: (2020)

Sudden Cardiac Arrest in Hemodialysis Patients with Wearable Cardioverter Defibrillator
por: Wan, Chingping, et al.
Publicado: (2013)

Oversensing of the wearable cardioverter defibrillator during bipolar ventricular stimulation
por: Manninger, Martin, et al.
Publicado: (2017)

Wearable Cardioverter Defibrillator　― Initial Experience in the Outpatient Setting in Japan ―
por: Horiguchi, Ai, et al.
Publicado: (2020)

The wearable cardioverter-defibrillator is not needed for most high-risk patients
por: Bhatt, Advay G., et al.
Publicado: (2020)

The wearable cardioverter-defibrillator is needed for most high-risk patients
por: Lee, Byron K.
Publicado: (2020)

Update on Wearable Cardioverter Defibrillator: A Comprehensive Review of Literature
por: Alsamman, Mrhaf, et al.
Publicado: (2022)

Cardiac arrhythmias in patients with COVID-19: Lessons from 2300 telemetric monitoring days on the intensive care unit
por: Parwani, Abdul Shokor, et al.
Publicado: (2021)

Use of the Wearable Cardioverter‐Defibrillator Among Patients With Myocarditis and Reduced Ejection Fraction or Ventricular Tachyarrhythmia: Data From a Multicenter Registry
por: El‐Battrawy, Ibrahim, et al.
Publicado: (2023)

The Automatic External Cardioverter-Defibrillator
por: Martínez-Rubio, Antoni, et al.
Publicado: (2004)

Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021)

COVID-19 vs. Classical Myocarditis Associated Myocardial Injury Evaluated by Cardiac Magnetic Resonance and Endomyocardial Biopsy
por: Tanacli, Radu, et al.
Publicado: (2021)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Double trouble: Management of implantable cardioverter-defibrillator infection in the setting of severe aortic stenosis
por: Contractor, Tahmeed, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_l7jj5u48rjplujhebfleoh1ldv